RE
ABMD

RBC Europe’s Abiomed Inc ABMD Stock Holding History

RBC Europe’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-65
Closed -$21.2K – 1241
2021
Q3 		$21.2K Hold
65
– – ﹤0.01% 773
2021
Q2 		$20.3K Hold
65
– – ﹤0.01% 812
2021
Q1 		$20.7K Sell
65
-25
-28% -$8K ﹤0.01% 753
2020
Q4 		$29.2K Hold
90
– – ﹤0.01% 631
2020
Q3 		$24.9K Hold
90
– – ﹤0.01% 598
2020
Q2 		$21.7K Sell
90
-100
-53% -$20.1K ﹤0.01% 611
2020
Q1 		$27.6K Hold
190
– – ﹤0.01% 493
2019
Q4 		$32.4K Buy
190
+35
+23% +$6.49K ﹤0.01% 550
2019
Q3 		$27.6K Buy
+155
New +$33.5K ﹤0.01% 569

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

RBC Europe's ABMD Position: Q4 2021 in Review

RBC Europe sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 65 shares — an estimated $21.2K sold.

RBC Europe first reported a position in ABMD in Q3 2019 and held it in 9 quarters. The position peaked at $32.4K in Q4 2019. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • RBC Europe reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • RBC Europe sold 65 Abiomed Inc shares in Q4 2021, an estimated $21.2K.
  • RBC Europe first reported a position in Abiomed Inc in Q3 2019 and held it in 9 quarters.
  • RBC Europe's Abiomed Inc position peaked at $32.4K in Q4 2019.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on RBC Europe's 13F filing for Q4 2021, filed 14 Nov 2022.